Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Oct 02, 2024

SELL
$12.09 - $14.68 $254,724 - $309,292
-21,069 Closed
0 $0
Q3 2021

Oct 02, 2024

BUY
$13.25 - $15.13 $234,988 - $268,330
17,735 Added 531.94%
21,069 $3.67 Billion
Q2 2021

Oct 02, 2024

BUY
$12.97 - $16.15 $43,241 - $53,844
3,334 New
3,334 $458 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $13.7B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Cannon Financial Strategists, Inc. Portfolio

Follow Cannon Financial Strategists, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannon Financial Strategists, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cannon Financial Strategists, Inc. with notifications on news.